- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04982653
Kort sting versus traditionel sutur til forebyggelse af incisionsbrok efter åben hepatektomi
Forebyggelse af incisionsbrok efter åben hepatektomi ved fascial lukning af små vævsbid: et randomiseret klinisk forsøg
This clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wall of the abdomen (an abdominal hernia) at the incision site better than the other.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
PRIMARY OBJECTIVE:
I. To assess whether small bites abdominal wall closure reduces the risk of developing incisional hernia following liver surgery.
SECONDARY OBJECTIVES:
I. To compare short-term perioperative outcomes between small bites and typical fascial closure technique.
II. To assess the hernia incidence rate of short stich versus (vs.) standard closure in subgroups of patients with inverted-L or midline incisions.
III. To assess the hernia incidence rate of Kawaguchi-Gayet hepatectomy complexity classifications I/II vs. III (hernia rate by extent of hepatectomy).
IV. To assess the hernia incidence rate of preoperative chemotherapy or no preoperative chemotherapy (hernia rate by exposure to preoperative chemotherapy).
V. To assess impact of small bites abdominal wall closure on health care quality of life following liver surgery.
VI. To assess safety of small tissue bites fascial closure suture technique versus conventional fascial closure following hepatectomy.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I (INTERVENTION): Patients undergo hepatectomy as planned using small bites fascial method for abdominal wall closure.
ARM II (CONTROL): Patients undergo hepatectomy as planned using conventional fascial method for abdominal wall closure.
After completion of study, patients are followed up at 1-4 weeks, and then at 3, 6, and 12 months.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 2
Kontakter og lokationer
Studiekontakt
- Navn: Timothy E Newhook, MD
- Telefonnummer: 713-792-6940
- E-mail: TNewhook@mdanderson.org
Studiesteder
-
-
Texas
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- M D Anderson Cancer Center
-
Kontakt:
- Timothy E. Newhook
- Telefonnummer: 713-792-6940
- E-mail: TNewhook@mdanderson.org
-
Ledende efterforsker:
- Timothy E. Newhook
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients undergoing hepatectomy for malignant diagnosis (primary or secondary) from 5/1/2021 through 11/1/2024 will be eligible for inclusion in this study
- Elective surgery
- Age >= 18
- Planned midline laparotomy incision or inverted-L incision
Exclusion Criteria:
- Pre-existing abdominal hernia
- History of mesh placement at prior laparotomy
- Pregnant women
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Arm I (hepatectomy using small bites fascial closure)
Patients undergo hepatectomy as planned using small bites fascial method for abdominal wall closure. |
Ancillary studies
Andre navne:
Undergo hepatectomy using small bites fascial method for abdominal wall closure
Andre navne:
Undergo hepatectomy using conventional fascial method for abdominal wall closure
Andre navne:
|
|
Aktiv komparator: Arm II (hepatectomy using conventional fascial method)
Patients undergo hepatectomy as planned using conventional fascial method for abdominal wall closure. |
Ancillary studies
Andre navne:
Undergo hepatectomy using small bites fascial method for abdominal wall closure
Andre navne:
Undergo hepatectomy using conventional fascial method for abdominal wall closure
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Radiographic incidence rate of incisional hernia
Tidsramme: Up to 12 months after surgery
|
Definition of incisional hernia will be based on the European Hernia Society: Any abdominal wall gap with or without a bulge in the area of a postoperative scar perceptible or palpable by clinical examination or imaging. Assessment of the primary outcome will occur at 3, 6, and 12 months with a computed tomography scan/magnetic resonance imaging. Scans will be read and assessed for incisional hernia by 3 independent assessors blinded to the allocation. A correlation coefficient will be determined for their assessments. The cumulative incidence rate of incisional hernia at 12 months will be estimated, along with the 95% confidence interval. |
Up to 12 months after surgery
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Infektion på operationsstedet
Tidsramme: Op til 90 dage efter operationen
|
Op til 90 dage efter operationen
|
|
|
Forekomst af operationsstedet
Tidsramme: Op til 90 dage efter operationen
|
Op til 90 dage efter operationen
|
|
|
Forekomst på operationsstedet, der kræver proceduremæssig indgriben
Tidsramme: Op til 90 dage efter operationen
|
Op til 90 dage efter operationen
|
|
|
Behov for genoperation
Tidsramme: Op til 90 dage efter operationen
|
Op til 90 dage efter operationen
|
|
|
Behov for reoperation sekundært til komplikation af abdominal lukning
Tidsramme: Op til 90 dage efter operationen
|
Op til 90 dage efter operationen
|
|
|
Enhver genindlæggelse relateret til brokreparation
Tidsramme: Op til 30 dage efter operationen
|
Op til 30 dage efter operationen
|
|
|
Postoperative complications
Tidsramme: Up to 90 days after surgery
|
Post-operative infection, complication or pain will be assessed using Chi-squared test or Fisher's exact test. |
Up to 90 days after surgery
|
|
Length of hospital stay (postoperatively)
Tidsramme: Up to 90 days after surgery
|
Will be compared between the two arms using two-sample t-test or Wilcoxon rank sum test. |
Up to 90 days after surgery
|
|
Health-related quality of life assessment
Tidsramme: Up to 12 months after surgery
|
Will use linear mixed effect modeling to assess the effects of time, arm as well as the interaction between arm and time. |
Up to 12 months after surgery
|
|
Incidence of adverse events (AEs)
Tidsramme: Up to 90 days after surgery
|
Will be summarized using descriptive statistics (frequency, percentage) by arm, AE type, severity and attribution. |
Up to 90 days after surgery
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Timothy E Newhook, MD, M.D. Anderson Cancer Center
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2021-0254
- 2021-0254 (Anden identifikator: M D Anderson Cancer Center)
- NCI-2021-04402 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .